Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products; ready-to-fill pellets and multiple unit pellets system; other drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. The company was incorporated in 1995 and is based in Hyderabad, India.
Rs. Crores · hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales 20.90
35.56
16.84
10.07
13.38
7.96
10.77
11.84
6.35
14.47
12.62
7.38
8.79
Expenses 18.66
34.13
15.96
9.06
12.44
7.03
9.45
11.05
5.62
14.28
12.06
5.85
7.39
Operating Profit 2.24
1.43
0.88
1.01
0.94
0.93
1.32
0.79
0.73
0.19
0.56
1.53
1.40
OPM % 10.72
4.02
5.23
10.03
7.03
11.68
12.26
6.67
11.50
1.31
4.44
20.73
15.93
Other Income 0.00
0.00
0.02
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.00
Depreciation 0.35
0.35
0.30
0.34
0.37
0.37
0.37
0.34
0.34
0.39
0.38
0.38
0.38
Interest 0.35
0.34
0.30
0.40
0.42
0.53
0.43
0.39
0.37
0.38
0.43
0.39
0.39
Profit before tax 1.54
0.74
0.30
0.27
0.15
0.03
0.52
0.07
0.02
-0.58
-0.25
0.77
0.63
Tax % 27.92
28.38
26.67
29.63
26.67
33.33
57.69
28.57
50.00
-39.66
-4.00
31.17
23.81
Net Profit 1.11
0.52
0.22
0.19
0.11
0.01
0.22
0.05
0.01
-0.35
-0.24
0.53
0.49
EPS in Rs 0.84
0.39
0.17
0.19
0.11
0.01
0.22
0.05
0.01
-0.35
-0.24
0.57
0.53
Annual · Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
75.88 36.93 43.26 51.31 58.96 51.33 51.34 48.08 51.80 57.43 50.68 40.02
Expenses
71.61 33.16 39.58 46.97 53.37 48.11 48.00 44.43 47.02 51.93 42.38 32.99
Operating Profit
4.27 3.77 3.68 4.34 5.59 3.22 3.34 3.65 4.78 5.50 8.30 7.03
OPM %
5.63 10.21 8.51 8.46 9.48 6.27 6.51 7.59 9.23 9.58 16.38 17.57
Other Income
0.00 0.01 0.01 0.01 0.10 3.86 0.12 0.09 0.14 0.09 0.15 0.37
Interest
1.46 1.72 1.59 1.62 1.68 1.42 1.54 1.59 1.88 2.36 2.57 2.72
Depreciation
1.36 1.42 1.54 1.60 1.76 1.37 1.46 1.71 2.40 2.58 2.91 3.63
Profit before tax
1.45 0.64 0.56 1.13 2.25 4.29 0.46 0.44 0.64 0.65 2.97 1.05
Tax %
28.28 54.69 25.00 21.24 28.89 23.54 28.26 9.09 50.00 73.85 40.74 33.33
Net Profit
1.04 0.30 0.42 0.89 1.59 3.28 0.33 0.41 0.32 0.16 1.75 0.70
EPS in Rs
0.79 0.30 0.42 0.96 1.82 3.75 0.38 0.52 0.41 0.22 2.42 0.97
Dividend Payout %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Annual · Rs. Crores — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
13.18 10.00 10.00 9.32 8.74 8.74 8.74 7.86 7.86 7.24 7.24 7.24
Reserves
35.34 24.11 23.82 22.38 19.62 18.02 14.74 15.29 11.46 11.75 7.82 6.07
Borrowings
11.61 16.91 14.93 15.63 16.43 12.97 9.57 9.83 13.62 15.43 19.99 21.27
Other Liabilities
11.72 7.56 7.55 9.31 11.66 10.15 24.96 49.79 73.48 21.11 17.44 19.63
Total Liabilities
71.85 58.58 56.30 56.64 56.45 49.88 58.01 82.77 106.42 55.53 52.49 54.21
Fixed Assets
11.55 12.17 11.63 12.86 13.97 13.83 10.52 11.85 13.51 13.64 15.18 18.32
CWIP
2.43 2.00 1.63 0.92 0.55 0.00 1.00 0.29 0.00 0.00 0.00 0.00
Investments
1.62 1.62 1.62 1.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
56.25 42.79 41.42 41.44 41.93 36.05 46.49 70.63 92.91 41.89 37.31 35.89
Total Assets
71.85 58.58 56.30 56.64 56.45 49.88 58.01 82.77 106.42 55.53 52.49 54.21
Annual · Rs. Crores — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
-7.37 3.16 1.96 2.24 0.77 1.62 2.48 1.19 6.88 1.70 3.05 1.75
Cash from Investing Activity
-1.13 -2.32 -1.21 -2.27 -2.44 -3.67 -0.84 -0.34 -2.21 -1.04 0.23 -1.10
Cash from Financing Activity
8.65 -0.87 -0.69 0.05 1.68 2.07 -1.79 -0.73 -4.80 -3.94 -3.42 -0.70
Net Cash Flow
0.16 -0.02 0.06 0.03 0.01 0.02 -0.15 0.12 -0.13 -3.28 -0.14 -0.06
Free Cash Flow
-8.54 0.83 0.94 1.38 -1.69 -2.05 1.63 0.85 4.60 0.66 3.28 0.65
CFO/OP %
-163.00 89.00 59.00 60.00 26.00 65.00 78.00 36.00 152.00 38.00 51.00 33.00
Annual · Days / % — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
135.31 125.22 117.87 116.31 141.52 147.41 180.94 367.66 501.49 99.46 183.51 249.90
Inventory Days
102.82 252.62 202.72 156.25 151.64 100.83 140.84 171.81 156.96 87.31 76.39 65.82
Days Payable
33.73 45.03 35.17 45.98 62.25 26.76 109.72 393.02 559.47 129.50 92.05 207.64
Cash Conversion Cycle
204.40 332.82 285.41 226.58 230.90 221.48 212.05 146.44 98.98 57.27 167.85 108.09
Working Capital Days
147.72 134.22 126.56 145.12 112.48 140.30 103.37 102.33 79.27 4.00 113.14 68.04
ROCE %
5.24 4.73 4.48 5.97 9.30 5.36 6.06 6.16 7.48 8.67 16.06 11.35
% holding — latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
45.08
54.39
54.39
54.39
54.39
54.39
54.39
54.39
55.41
55.41
55.41
52.13
Public
54.92
45.61
45.61
45.61
45.61
45.61
45.61
45.61
44.60
44.60
44.59
47.87
No. of Shareholders
4,435
4,464
4,597
4,718
5,189
5,252
5,073
5,073
4,755
4,734
4,032
3,957